Retour
Fourchette du Jour
7,79 €
8,12 €
Fourchette 52 Semaines
2,60 €
10,69 €
Volume
300 184
Moyenne 50J / 200J
7,57 €
/
5,32 €
Clôture Précédente
7,75 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (626 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | -35,6 | 0,4 |
| P/B | 4,6 | 2,9 |
| ROE % | -12,0 | 3,7 |
| Net Margin % | -3,6 | 3,9 |
| Rev Growth 5Y % | 7,6 | 10,0 |
| D/E | 0,4 | 0,2 |
Objectif de Cours des Analystes
Hold
6,80 €
-14.6%
Low: 5,00 €
High: 8,00 €
P/E Prévisionnel
31,6
BPA Prévisionnel
0,25 €
Croissance BPA (est.)
+0,0%
CA Est.
940 M
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2028 |
0,52 €
0,52 € – 0,53 €
|
1,1 B | 1 |
| FY2027 |
0,34 €
0,24 € – 0,43 €
|
1 B | 2 |
| FY2026 |
0,25 €
0,21 € – 0,30 €
|
940 M | 2 |
Points Clés
Revenue grew 7,56% annually over 5 years — modest growth
Debt/Equity of 0,43 — conservative balance sheet
Generating 26,60M in free cash flow
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 4,20%
Capital efficient — spends only 0,73% of revenue on capex
Croissance
Revenue Growth (5Y)
7,56%
Revenue (1Y)11,76%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Qualité
Return on Equity
-12,02%
ROIC-6,64%
Net Margin-3,55%
Op. Margin-3,49%
Sécurité
Debt / Equity
0,43
Current Ratio1,07
Interest Coverage-6,45
Valorisation
P/E Ratio
-35,63
P/B Ratio4,60
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 11,76% | Revenue Growth (3Y) | 11,39% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 7,56% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 853,70M | Net Income (TTM) | -30,31M |
| ROE | -12,02% | ROA | -5,44% |
| Gross Margin | 68,50% | Operating Margin | -3,49% |
| Net Margin | -3,55% | Free Cash Flow (TTM) | 26,60M |
| ROIC | -6,64% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,43 | Current Ratio | 1,07 |
| Interest Coverage | -6,45 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -35,63 | P/B Ratio | 4,60 |
| P/S Ratio | 1,27 | PEG Ratio | -0,44 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 1,08B | Enterprise Value | 1,12B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 853,70M | 763,86M | 688,09M | 698,64M | 637,80M |
| Net Income | -30,31M | -21,34M | -40,67M | -6,52M | -43,99M |
| EPS (Diluted) | -0,22 | -0,16 | -0,30 | -0,05 | -0,33 |
| Gross Profit | 584,79M | 132,06M | 101,29M | 135,37M | 161,79M |
| Operating Income | -29,76M | -23,18M | -49,40M | -4,41M | 74,82M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 557,23M | 579,84M | 547,66M | 562,87M | 538,61M |
| Total Liabilities | 294,32M | 280,03M | 247,85M | 209,13M | 180,65M |
| Shareholders' Equity | 234,97M | 269,26M | 269,26M | 332,36M | 334,56M |
| Total Debt | 101,08M | 113,04M | 113,04M | 84,81M | 82,63M |
| Cash & Equivalents | 64,14M | 56,96M | 56,95M | 184,45M | 203,70M |
| Current Assets | 176,11M | 173,14M | 173,14M | 240,96M | 250,93M |
| Current Liabilities | 164,81M | 138,60M | 138,60M | 105,31M | 78,57M |